Globitair

Disease outbreaks

WHO says 2 new candidate vaccines to join Ebola trial in DR Congo

Anadolu AgencyDemocratic Republic of the Congo

ChAdOx1 BDBV, mRNA-1469 vaccines designed specifically for Bundibugyo virus in Congo as outbreak has killed 5,000, infected 10,000

Read the full story at Anadolu AgencyOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about Democratic Republic of the Congo

More on Disease outbreaks